Emerging roles of microRNAs as diagnostics and potential therapeutic interest in type 2 diabetes mellitus

doi:10.12998/wjcc.v12.i3.525

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3258)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

WORD

HTML

2027

Figures (1-6)

233

Tables (1-3)

208

Sum=2600

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

159

Download

348

Sum=507

Jan 26, 2024 (publication date) through Feb 11, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Clin Cases. Jan 26, 2024; 12(3): 525-537
Published online Jan 26, 2024. doi: 10.12998/wjcc.v12.i3.525

Full Size Figure Download Figure

Figure 3 MiRNA regulation in the advanced glycation end product/receptor of advanced glycation end products activated nuclear factor pathway. Advanced glycation end product - receptor of advanced glycation end product interaction activates the nuclear factor pathway, which is inhibited by miR-200b, miR-200c, and miR-471-3p and upregulated by miR-124 and miR-146a. AGE: Advanced glycation end product; RAGE: Receptor of advanced glycation end product; MAPK: Mitogen-activated protein kinases; NF-κB: Nuclear factor kappa beta; TNF-α: Tumor necrosis factor.

Citation: Shrivastav D, Singh DD. Emerging roles of microRNAs as diagnostics and potential therapeutic interest in type 2 diabetes mellitus. World J Clin Cases 2024; 12(3): 525-537
URL: https://www.wjgnet.com/2307-8960/full/v12/i3/525.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i3.525